Medicine guide

Eribulin Zentiva

On the Bulgarian pack: Ерибулин Зентива 0,44 mg/ml инжекционен разтвор

0.44 mg/ml · solution for injection

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Eribulin
Made by
Zentiva k.s.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01XX41

Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byZentiva k.s. · Czech Republic
Active substanceEribulin
Used inCancer treatments and immune-system medicines
Strength0.44 mg/ml
Formsolution for injection
Pack sizes1 · 6
ClassificationL01XX41 · Cancer treatments and immune-system medicines
Name in the registerЕрибулин Зентива 0,44 mg/ml инжекционен разтвор
Reg. no.20240045

Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician

Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.